Quetiapine: Efficacy, tolerability and safety in schizophrenia

Chanoch Miodownik, Vladimir Lerner

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations


Quetiapine, a dibenzothiazepine derivative, is an atypical antipsychotic, multireceptor antagonist that has a preclinical profile similar to clozapine. Randomized studies have demonstrated the efficacy of quetiapine relative to placebo in the treatment of acute relapse and the long-term management of schizophrenia. Quetiapine is generally well tolerated relative to other antipsychotic medications, although side effects include sedation, orthostatic hypotension, anticholinergic and metabolic side effects. The purpose of this article is to critically review the current literature on quetiapine with an emphasis on emergent themes and key findings in the use of this agent for the treatment of schizophrenia. There are also continued efforts to understand, predict and manage the side-effect risk with quetiapine.

Original languageEnglish
Pages (from-to)983-992
Number of pages10
JournalExpert Review of Neurotherapeutics
Issue number7
StatePublished - 20 Jul 2006


  • Doses
  • Quetiapine
  • Schizophrenia
  • Side effects
  • Treatment


Dive into the research topics of 'Quetiapine: Efficacy, tolerability and safety in schizophrenia'. Together they form a unique fingerprint.

Cite this